{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:23:59Z","timestamp":1791390239879,"version":"4.3.3"},"reference-count":101,"publisher":"Portland Press Ltd.","issue":"6","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Neutrophils, until recently, have typically been considered a homogeneous population of terminally differentiated cells with highly conserved functions in homeostasis and disease. In hepatocellular carcinoma (HCC), tumour-associated neutrophils (TANs) are predominantly thought to play a pro-tumour role, promoting all aspects of HCC development and progression. Recent developments in single-cell technologies are now providing a greater insight and appreciation for the level of cellular heterogeneity displayed by TANs in the HCC tumour microenvironment, which we have been able to correlate with other TAN signatures in datasets for gastric cancer, pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC). TANs with classical pro-tumour signatures have been identified as well as neutrophils primed for anti-tumour functions that, if activated and expanded, could become a potential therapeutic approach. In recent years, therapeutic targeting of neutrophils in HCC has been typically focused on impairing the recruitment of pro-tumour neutrophils. This has now been coupled with immune checkpoint blockade with the aim to stimulate lymphocyte-mediated anti-tumour immunity whilst impairing neutrophil-mediated immunosuppression. As a result, neutrophil-directed therapies are now entering clinical trials for HCC. Pharmacological targeting along with ex vivo reprogramming of neutrophils in HCC patients is, however, in its infancy and a greater understanding of neutrophil heterogeneity, with a view to exploit it, may pave the way for improved immunotherapy outcomes. This review will cover the recent developments in our understanding of neutrophil heterogeneity in HCC and how neutrophils can be harnessed to improve HCC immunotherapy.<\/jats:p>","DOI":"10.1042\/ebc20220245","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T12:21:01Z","timestamp":1691065261000},"page":"941-955","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Harnessing neutrophil plasticity for HCC immunotherapy"],"prefix":"10.1042","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6397-0130","authenticated-orcid":false,"given":"Erik","family":"Ramon-Gil","sequence":"additional","affiliation":[{"name":"1Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, U.K."},{"name":"2The Newcastle University Centre for Cancer, Newcastle University, Newcastle Upon Tyne, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3592-7469","authenticated-orcid":false,"given":"Daniel","family":"Geh","sequence":"additional","affiliation":[{"name":"1Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, U.K."},{"name":"2The Newcastle University Centre for Cancer, Newcastle University, Newcastle Upon Tyne, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6443-2396","authenticated-orcid":false,"given":"Jack","family":"Leslie","sequence":"additional","affiliation":[{"name":"1Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, U.K."},{"name":"2The Newcastle University Centre for Cancer, Newcastle University, Newcastle Upon Tyne, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"2023092809013298500_B1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"2023092809013298500_B2","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"key":"2023092809013298500_B3","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"2023092809013298500_B4","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J. Hepatol."},{"key":"2023092809013298500_B5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2023092809013298500_B6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.immuni.2010.11.011","article-title":"Neutrophils, from marrow to microbes","volume":"33","author":"Borregaard","year":"2010","journal-title":"Immunity"},{"key":"2023092809013298500_B7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41575-021-00568-5","article-title":"Neutrophils as potential therapeutic targets in hepatocellular carcinoma","volume":"19","author":"Geh","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2023092809013298500_B8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"2023092809013298500_B9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","article-title":"Neutrophils in cancer: heterogeneous and multifaceted","volume":"22","author":"Hedrick","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"2023092809013298500_B10","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"2023092809013298500_B11","doi-asserted-by":"publisher","first-page":"1282.e1218","DOI":"10.1016\/j.cell.2020.10.003","article-title":"Co-option of neutrophil fates by tissue environments","volume":"183","author":"Ballesteros","year":"2020","journal-title":"Cell"},{"key":"2023092809013298500_B12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.cell.2013.04.040","article-title":"Rhythmic modulation of the hematopoietic niche through neutrophil clearance","volume":"153","author":"Casanova-Acebes","year":"2013","journal-title":"Cell"},{"key":"2023092809013298500_B13","doi-asserted-by":"publisher","first-page":"390.e310","DOI":"10.1016\/j.immuni.2019.01.002","article-title":"A neutrophil timer coordinates immune defense and vascular protection","volume":"50","author":"Adrover","year":"2019","journal-title":"Immunity"},{"key":"2023092809013298500_B14","doi-asserted-by":"publisher","first-page":"e20220011","DOI":"10.1084\/jem.20220011","article-title":"Neutrophil phenotypes and functions in cancer: A consensus statement","volume":"219","author":"Quail","year":"2022","journal-title":"J. Exp. Med."},{"key":"2023092809013298500_B15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41586-020-2227-7","article-title":"Mouse models of neutropenia reveal progenitor-stage-specific defects","volume":"582","author":"Muench","year":"2020","journal-title":"Nature"},{"key":"2023092809013298500_B16","doi-asserted-by":"publisher","first-page":"303.e305","DOI":"10.1016\/j.immuni.2020.06.005","article-title":"Combinatorial single-cell analyses of granulocyte-monocyte progenitor heterogeneity reveals an early uni-potent neutrophil progenitor","volume":"53","author":"Kwok","year":"2020","journal-title":"Immunity"},{"key":"2023092809013298500_B17","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/s41590-020-0736-z","article-title":"Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection","volume":"21","author":"Xie","year":"2020","journal-title":"Nat. Immunol."},{"key":"2023092809013298500_B18","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1038\/s41467-021-22973-9","article-title":"The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments","volume":"12","author":"Grieshaber-Bouyer","year":"2021","journal-title":"Nat. Commun."},{"key":"2023092809013298500_B19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-017-0707-7","article-title":"Neutrophils in cancer: prognostic role and therapeutic strategies","volume":"16","author":"Ocana","year":"2017","journal-title":"Mol. Cancer"},{"key":"2023092809013298500_B20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1182\/blood-2010-01-259028","article-title":"In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days","volume":"116","author":"Pillay","year":"2010","journal-title":"Blood"},{"key":"2023092809013298500_B21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.celrep.2014.12.039","article-title":"Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer","volume":"10","author":"Sagiv","year":"2015","journal-title":"Cell Reports"},{"key":"2023092809013298500_B22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"2023092809013298500_B23","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.1038\/s41388-021-02054-3","article-title":"Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma","volume":"40","author":"Bischoff","year":"2021","journal-title":"Oncogene"},{"key":"2023092809013298500_B24","doi-asserted-by":"publisher","first-page":"e2103240118","DOI":"10.1073\/pnas.2103240118","article-title":"Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2023092809013298500_B25","doi-asserted-by":"publisher","first-page":"103315","DOI":"10.1016\/j.ebiom.2021.103315","article-title":"Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression","volume":"66","author":"Chen","year":"2021","journal-title":"EBioMedicine"},{"key":"2023092809013298500_B26","doi-asserted-by":"publisher","first-page":"eabk2756","DOI":"10.1126\/scitranslmed.abk2756","article-title":"Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis","volume":"14","author":"Wang","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"2023092809013298500_B27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","article-title":"Liver tumour immune microenvironment subtypes and neutrophil heterogeneity","volume":"612","author":"Xue","year":"2022","journal-title":"Nature"},{"key":"2023092809013298500_B28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/procel\/pwac045","article-title":"A YAP\/TAZ-CD54 axis is required for CXCR2-CD44- tumor-specific neutrophils to suppress gastric cancer","volume":"14","author":"Nie","year":"2022","journal-title":"Protein Cell"},{"key":"2023092809013298500_B29","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/gutjnl-2021-326070","article-title":"Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment","volume":"72","author":"Wang","year":"2022","journal-title":"Gut"},{"key":"2023092809013298500_B30","doi-asserted-by":"publisher","first-page":"1503.e1508","DOI":"10.1016\/j.ccell.2022.10.008","article-title":"High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer","volume":"40","author":"Salcher","year":"2022","journal-title":"Cancer Cell."},{"key":"2023092809013298500_B31","doi-asserted-by":"publisher","first-page":"829.e820","DOI":"10.1016\/j.cell.2019.10.003","article-title":"Landscape and dynamics of single immune cells in hepatocellular carcinoma","volume":"179","author":"Zhang","year":"2019","journal-title":"Cell"},{"key":"2023092809013298500_B32","doi-asserted-by":"publisher","first-page":"377.e321","DOI":"10.1016\/j.cell.2020.08.040","article-title":"Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular Carcinoma","volume":"183","author":"Sharma","year":"2020","journal-title":"Cell"},{"key":"2023092809013298500_B33","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","article-title":"Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"75","author":"Ma","year":"2021","journal-title":"J. Hepatol."},{"key":"2023092809013298500_B34","doi-asserted-by":"publisher","first-page":"418.e416","DOI":"10.1016\/j.ccell.2019.08.007","article-title":"Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer","volume":"36","author":"Ma","year":"2019","journal-title":"Cancer Cell."},{"key":"2023092809013298500_B35","doi-asserted-by":"publisher","first-page":"404.e416","DOI":"10.1016\/j.cell.2020.11.041","article-title":"Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma","volume":"184","author":"Sun","year":"2021","journal-title":"Cell"},{"key":"2023092809013298500_B36","doi-asserted-by":"publisher","first-page":"1342.e1316","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"key":"2023092809013298500_B37","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jhep.2020.05.039","article-title":"Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma","volume":"73","author":"Zhang","year":"2020","journal-title":"J. Hepatol."},{"key":"2023092809013298500_B38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41586-019-1373-2","article-title":"A human liver cell atlas reveals heterogeneity and epithelial progenitors","volume":"572","author":"Aizarani","year":"2019","journal-title":"Nature"},{"key":"2023092809013298500_B39","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1136\/gutjnl-2021-326259","article-title":"CXCR2 inhibition enables NASH-HCC immunotherapy","volume":"71","author":"Leslie","year":"2022","journal-title":"Gut"},{"key":"2023092809013298500_B40","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/ijc.29298","article-title":"Identification of HERC5 and its potential role in NSCLC progression","volume":"136","author":"Wrage","year":"2015","journal-title":"Int. J. Cancer"},{"key":"2023092809013298500_B41","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3390\/cancers14071852","article-title":"Enhancer RNA transcription is essential for a novel CSF1 enhancer in triple-negative breast cancer","volume":"14","author":"Lewis","year":"2022","journal-title":"Cancers"},{"key":"2023092809013298500_B42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41416-018-0137-3","article-title":"G1P3 (IFI6), a mitochondrial localised antiapoptotic protein, promotes metastatic potential of breast cancer cells through mtROS","volume":"119","author":"Cheriyath","year":"2018","journal-title":"Br. J. Cancer"},{"key":"2023092809013298500_B43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13046-020-01646-3","article-title":"IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress","volume":"39","author":"Liu","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2023092809013298500_B44","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26318","article-title":"Hes4: A potential prognostic biomarker for newly diagnosed patients with high-grade osteosarcoma","volume":"64","author":"McManus","year":"2017","journal-title":"Pediatric Blood Cancer"},{"key":"2023092809013298500_B45","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10549-020-05646-x","article-title":"Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer","volume":"181","author":"Aljohani","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"2023092809013298500_B46","doi-asserted-by":"publisher","first-page":"1997385","DOI":"10.1080\/2162402X.2021.1997385","article-title":"Cancer-specific type-I interferon receptor signaling promotes cancer stemness and effector CD8+ T-cell exhaustion","volume":"10","author":"Gong","year":"2021","journal-title":"Oncoimmunology"},{"key":"2023092809013298500_B47","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s13402-021-00651-8","article-title":"IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt\/\u03b2-catenin signaling","volume":"44","author":"Li","year":"2021","journal-title":"Cell. Oncol. (Dordrecht)"},{"key":"2023092809013298500_B48","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fmolb.2019.00148","article-title":"Emerging functions of human IFIT proteins in cancer","volume":"6","author":"Pidugu","year":"2019","journal-title":"Front. Mol. Biosci."},{"key":"2023092809013298500_B49","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.3390\/ijms21144934","article-title":"Interferon-induced transmembrane protein 1 (IFITM1) promotes distant metastasis of small cell lung cancer","volume":"21","author":"Sakamoto","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"2023092809013298500_B50","doi-asserted-by":"publisher","first-page":"86039","DOI":"10.18632\/oncotarget.13325","article-title":"Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer","volume":"7","author":"Sari","year":"2016","journal-title":"Oncotarget"},{"key":"2023092809013298500_B51","doi-asserted-by":"publisher","first-page":"8139","DOI":"10.2147\/OTT.S220698","article-title":"Decreased IFIT2 expression in human non-small-cell lung cancer tissues is associated with cancer progression and poor survival of the patients","volume":"12","author":"Su","year":"2019","journal-title":"OncoTargets Ther."},{"key":"2023092809013298500_B52","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.3390\/cancers12113379","article-title":"Osteopontin: a key regulator of tumor progression and immunomodulation","volume":"12","author":"Moorman","year":"2020","journal-title":"Cancers"},{"key":"2023092809013298500_B53","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1111\/1759-7714.14108","article-title":"Tumor-associated macrophages (TAMs)-derived osteopontin (OPN) upregulates PD-L1 expression and predicts poor prognosis in non-small cell lung cancer (NSCLC)","volume":"12","author":"Li","year":"2021","journal-title":"Thoracic Cancer"},{"key":"2023092809013298500_B54","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41374-020-0441-4","article-title":"CCL3\u2013CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways","volume":"100","author":"Kodama","year":"2020","journal-title":"Lab. Invest."},{"key":"2023092809013298500_B55","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/1759-7714.12643","article-title":"High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma","volume":"9","author":"Li","year":"2018","journal-title":"Thoracic Cancer"},{"key":"2023092809013298500_B56","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.21037\/atm-22-5270","article-title":"Single-cell transcriptome analysis of tumor immune microenvironment characteristics in colorectal cancer liver metastasis","volume":"10","author":"Geng","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"2023092809013298500_B57","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.chembiol.2015.08.006","article-title":"An analysis of MIF structural features that control functional activation of CD74","volume":"22","author":"Pantouris","year":"2015","journal-title":"Chem. Biol."},{"key":"2023092809013298500_B58","doi-asserted-by":"publisher","first-page":"e1185","DOI":"10.1002\/cti2.1185","article-title":"Proteomic analysis of extracellular vesicles reveals an immunogenic cargo in rheumatoid arthritis synovial fluid","volume":"9","author":"Foers","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"2023092809013298500_B59","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.3390\/cancers13143626","article-title":"Prognostic impact of immunoglobulin Kappa C (IGKC) in early breast cancer","volume":"13","author":"Schmidt","year":"2021","journal-title":"Cancers"},{"key":"2023092809013298500_B60","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.4161\/onci.21653","article-title":"Immunoglobulin kappa chain as an immunologic biomarker of prognosis and chemotherapy response in solid tumors","volume":"1","author":"Schmidt","year":"2012","journal-title":"Oncoimmunology"},{"key":"2023092809013298500_B61","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/JLB.3A0420-242RRR","article-title":"Macrophage migration inhibitory factor inhibits neutrophil apoptosis by inducing cytokine release from mononuclear cells","volume":"110","author":"Schindler","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"2023092809013298500_B62","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41419-022-04552-y","article-title":"Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma","volume":"13","author":"Fukuda","year":"2022","journal-title":"Cell Death Dis."},{"key":"2023092809013298500_B63","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ccell.2016.06.001","article-title":"Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer","volume":"30","author":"Singhal","year":"2016","journal-title":"Cancer Cell."},{"key":"2023092809013298500_B64","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1172\/JCI77053","article-title":"Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer","volume":"124","author":"Eruslanov","year":"2014","journal-title":"J. Clin. Invest."},{"key":"2023092809013298500_B65","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41573-019-0054-z","article-title":"Neutrophils as emerging therapeutic targets","volume":"19","author":"N\u00e9meth","year":"2020","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2023092809013298500_B66","doi-asserted-by":"publisher","first-page":"e004820","DOI":"10.1136\/jitc-2022-004820","article-title":"Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex","volume":"10","author":"Rees","year":"2022","journal-title":"J. Immunotherapy Cancer"},{"key":"2023092809013298500_B67","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/imr.13159","article-title":"Neutrophils as immune effector cells in antibody therapy in cancer","volume":"314","author":"Behrens","year":"2023","journal-title":"Immunol. Rev."},{"key":"2023092809013298500_B68","doi-asserted-by":"publisher","first-page":"101581","DOI":"10.1016\/j.smim.2021.101581","article-title":"Therapeutic exploitation of neutrophils to fight cancer","volume":"57","author":"Gruijs","year":"2021","journal-title":"Semin. Immunol."},{"key":"2023092809013298500_B69","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/hep4.1438","article-title":"Dysregulated Lipid Transport Proteins Correlate With Pathogenesis and Outcome in Severe Alcoholic Hepatitis","volume":"3","author":"Maras","year":"2019","journal-title":"Hepatol. Commun."},{"key":"2023092809013298500_B70","doi-asserted-by":"publisher","first-page":"976216","DOI":"10.3389\/fnut.2022.976216","article-title":"Neutrophil-albumin ratio as a biomarker for postoperative complications and long-term prognosis in patients with colorectal cancer undergoing surgical treatment","volume":"9","author":"Xie","year":"2022","journal-title":"Front. Nutrition"},{"key":"2023092809013298500_B71","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4137\/BMI.S33191","article-title":"Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Retinol-Binding Protein 4 (RBP4) in Type 2 Diabetic Patients with Nephropathy","volume":"11","author":"Mahfouz","year":"2016","journal-title":"Biomarker Insights"},{"key":"2023092809013298500_B72","doi-asserted-by":"publisher","first-page":"BSR20210328","DOI":"10.1042\/BSR20210328","article-title":"Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma","volume":"41","author":"Li","year":"2021","journal-title":"Biosci. Rep."},{"key":"2023092809013298500_B73","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3390\/cancers11081097","article-title":"Apolipoprotein A-I (ApoA-I), immunity, inflammation and cancer","volume":"11","author":"Georgila","year":"2019","journal-title":"Cancers"},{"key":"2023092809013298500_B74","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/pmic.200500257","article-title":"Proteome analysis of hepatocellular carcinoma by laser capture microdissection","volume":"6","author":"Ai","year":"2006","journal-title":"Proteomics"},{"key":"2023092809013298500_B75","doi-asserted-by":"publisher","first-page":"e12772","DOI":"10.1111\/cpr.12772","article-title":"Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review","volume":"53","author":"Hu","year":"2020","journal-title":"Cell Prolif."},{"key":"2023092809013298500_B76","doi-asserted-by":"publisher","first-page":"6818","DOI":"10.1038\/ncomms7818","article-title":"NF\u03baB1 is a suppressor of neutrophil-driven hepatocellular carcinoma","volume":"6","author":"Wilson","year":"2015","journal-title":"Nat. Commun."},{"key":"2023092809013298500_B77","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ccell.2016.04.014","article-title":"CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma","volume":"29","author":"Steele","year":"2016","journal-title":"Cancer Cell."},{"key":"2023092809013298500_B78","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12943-021-01355-1","article-title":"Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin","volume":"20","author":"Cheng","year":"2021","journal-title":"Mol. Cancer"},{"key":"2023092809013298500_B79","doi-asserted-by":"publisher","first-page":"eaax0428","DOI":"10.1126\/scitranslmed.aax0428","article-title":"Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer","volume":"11","author":"Li","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"2023092809013298500_B80","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1158\/2159-8290.CD-15-0224","article-title":"Targeting YAP-dependent MDSC infiltration impairs tumor progression","volume":"6","author":"Wang","year":"2016","journal-title":"Cancer Discovery"},{"key":"2023092809013298500_B81","doi-asserted-by":"publisher","first-page":"862125","DOI":"10.3389\/fphar.2022.862125","article-title":"CXCR2 small-molecule antagonist combats chemoresistance and enhances immunotherapy in triple-negative breast cancer","volume":"13","author":"Ghallab","year":"2022","journal-title":"Front. Pharmacol."},{"key":"2023092809013298500_B82","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1038\/onc.2016.367","article-title":"CXCL2\/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer","volume":"36","author":"Zhang","year":"2017","journal-title":"Oncogene"},{"key":"2023092809013298500_B83","doi-asserted-by":"publisher","first-page":"689613","DOI":"10.3389\/fcell.2021.689613","article-title":"Antitumor and radiosensitization effects of a CXCR2 inhibitor in nasopharyngeal carcinoma","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Developmental Biol."},{"key":"2023092809013298500_B84","doi-asserted-by":"publisher","first-page":"13405","DOI":"10.18632\/aging.203074","article-title":"Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment","volume":"13","author":"Henriques","year":"2021","journal-title":"Aging"},{"key":"2023092809013298500_B85","doi-asserted-by":"publisher","first-page":"e0139237","DOI":"10.1371\/journal.pone.0139237","article-title":"CXCR2 inhibition combined with sorafenib improved antitumor and antiangiogenic response in preclinical models of ovarian cancer","volume":"10","author":"Devapatla","year":"2015","journal-title":"PLoS ONE"},{"key":"2023092809013298500_B86","doi-asserted-by":"publisher","first-page":"3339.e3338","DOI":"10.1016\/j.molcel.2021.07.003","article-title":"N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression","volume":"81","author":"Dai","year":"2021","journal-title":"Mol. Cell."},{"key":"2023092809013298500_B87","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1136\/gutjnl-2022-327230","article-title":"Targeting tumour-intrinsic N(7)-methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy","volume":"72","author":"Liu","year":"2022","journal-title":"Gut"},{"key":"2023092809013298500_B88","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"2023092809013298500_B89","doi-asserted-by":"publisher","first-page":"TPS631","DOI":"10.1200\/JCO.2023.41.4_suppl.TPS631","article-title":"A phase I\/II study of the CXCR2 inhibitor, AZD5069, in combination with durvalumab, in patients (pts) with advanced hepatocellular carcinoma (HCC)","volume":"41","author":"Evans","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"2023092809013298500_B90","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1158\/1078-0432.CCR-21-2517","article-title":"Cabozantinib enhances anti-PD1 activity and elicits a neutrophil-based immune response in hepatocellular carcinoma","volume":"28","author":"Esteban-Fabr\u00f3","year":"2022","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"2023092809013298500_B91","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ccell.2023.01.002","article-title":"Neutrophil-activating therapy for the treatment of cancer","volume":"41","author":"Linde","year":"2023","journal-title":"Cancer Cell."},{"key":"2023092809013298500_B92","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"key":"2023092809013298500_B93","doi-asserted-by":"publisher","first-page":"e006239","DOI":"10.1136\/jitc-2022-006239","article-title":"IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM","volume":"11","author":"Zannikou","year":"2023","journal-title":"J. Immunotherapy Cancer"},{"key":"2023092809013298500_B94","doi-asserted-by":"publisher","first-page":"2250.e2220","DOI":"10.1053\/j.gastro.2020.02.011","article-title":"Persistent polyfunctional chimeric antigen receptor T cells that target glypican 3 eliminate orthotopic hepatocellular carcinomas in mice","volume":"158","author":"Li","year":"2020","journal-title":"Gastroenterology"},{"key":"2023092809013298500_B95","article-title":"ClinicalTrials.gov","author":"NCT05003895","year":"2021"},{"key":"2023092809013298500_B96","doi-asserted-by":"publisher","first-page":"111128","DOI":"10.1016\/j.celrep.2022.111128","article-title":"Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy","volume":"40","author":"Chang","year":"2022","journal-title":"Cell Rep."},{"key":"2023092809013298500_B97","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41590-021-00968-4","article-title":"Distinct transcription factor networks control neutrophil-driven inflammation","volume":"22","author":"Khoyratty","year":"2021","journal-title":"Nat. Immunol."},{"key":"2023092809013298500_B98","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nmeth865","article-title":"Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8","volume":"3","author":"Wang","year":"2006","journal-title":"Nat. Methods"},{"key":"2023092809013298500_B99","doi-asserted-by":"publisher","first-page":"840894","DOI":"10.3389\/fcell.2022.840894","article-title":"Engraftment, fate, and function of HoxB8-conditional neutrophil progenitors in the unconditioned murine host","volume":"10","author":"Cohen","year":"2022","journal-title":"Front. Cell Developmental Biol."},{"key":"2023092809013298500_B100","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.jcyt.2017.08.012","article-title":"Granulocyte transfusions: A concise review for practitioners","volume":"19","author":"Gea-Banacloche","year":"2017","journal-title":"Cytotherapy"},{"key":"2023092809013298500_B101","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41368-021-00146-0","article-title":"From bulk, single-cell to spatial RNA sequencing","volume":"13","author":"Li","year":"2021","journal-title":"Int. J. Oral Sci."}],"container-title":["Essays in Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/essaysbiochem\/article-pdf\/67\/6\/941\/950428\/ebc-2022-0245c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/essaysbiochem\/article-pdf\/67\/6\/941\/950428\/ebc-2022-0245c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T09:01:59Z","timestamp":1695891719000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/essaysbiochem\/article\/67\/6\/941\/233348\/Harnessing-neutrophil-plasticity-for-HCC"}},"subtitle":[],"editor":[{"given":"Cathy","family":"Tournier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Awen","family":"Gallimore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":101,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,9,28]]},"published-print":{"date-parts":[[2023,9,28]]}},"URL":"https:\/\/doi.org\/10.1042\/ebc20220245","relation":{},"ISSN":["0071-1365","1744-1358"],"issn-type":[{"value":"0071-1365","type":"print"},{"value":"1744-1358","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,9]]}}}